Characteristics and Mortality of Patients With Cancer Diagnosed With SARS-CoV-2 in Northern Portugal
Anticancer Research · 2025
DOI: 10.21873/anticanres.17555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von José Taveira-Barbosa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal; up201502150@up…. Hauptthemen laut MEDLINE: COVID-19, Neoplasms.
Abstract (Originalsprache)
BACKGROUND/AIM: Patients with cancer have been found to be at higher risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which may negatively affect their prognosis. This study aimed to compare sociodemographic and clinical characteristics, as well as mortality, between cancer patients with and without SARS-CoV-2 infection. PATIENTS AND METHODS: Patients with tumors of the esophagus, stomach, colon and rectum, pancreas, lung, skin-melanoma, breast, cervix, non-Hodgkin lymphoma, and leukemia diagnosed between March 2019 and March 2021, and followed at the Portuguese Oncology Institute of Porto (IPO-Porto) were identified. Patients with SARS-CoV-2 infection between March 2020 and September 2021 were compared to patients without infection. Vital status was assessed up to March 2024. Cox proportional hazards regression was used to estimate crude, age- and stage-adjusted hazard ratios (HRs) and 95% confidence intervals (95%CIs) for mortality. RESULTS: During follow-up, one-third of patients who had SARS-CoV-2 died (vs. one-fourth), corresponding to an adjusted HR (95%CI) of 1.39 (1.03-1.88). Significantly higher adjusted HRs were observed for residents outside Porto's Metropolitan Area (HR=1.94, 95%CI=1.22-3.09), patients with lung cancer (HR=2.02, 95%CI=1.12-3.66) and patients with surgery as the first cancer treatment received at IPO-Porto (HR=2.00, 95%CI=1.08-3.74). CONCLUSION: Cancer patients with SARS-CoV-2 infection had higher mortality compared to those without infection, and specific subgroups of patients at higher risk were identified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal; up201502150@up.pt.
- Serviço de Epidemiologia, Instituto Português de Oncologia do Porto FG, EPE, Porto, Portugal.
- Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
- Grupo de Investigação em Epidemiologia, Resultados, Economia e Gestão em Oncologia-Centro de Investigação (CI-IPOP) & Porto Comprehensive Cancer Center (Porto.CCC) & RISE@CI-IPOP (Rede de Investigação em Saúde), Institu…
- Serviço de Doenças Infeciosas/UL PPCIRA, Instituto Português de Oncologia do Porto FG, EPE, Porto, Portugal.
- Abordagem de Lesões Pré-Cancerosas e Cancro Precoce-Centro de Investigação (CI-IPOP), Instituto Português de Oncologia do Porto (IPO-Porto) & Porto Comprehensive Cancer Center (Porto.CCC) & RISE@CI-IPOP (Rede de Investi…
Zitieren
APA
Taveira-Barbosa, J., Garcia, T., Lebre, A., Fontes, F., Brandão, M., Calisto, R., Turé, R., Bento, M. J., Lunet, N., Morais, S., & Lopes-Conceição, L. (2025). Characteristics and Mortality of Patients With Cancer Diagnosed With SARS-CoV-2 in Northern Portugal. Anticancer Research. https://doi.org/10.21873/anticanres.17555
Vancouver
Taveira-Barbosa J, Garcia T, Lebre A, Fontes F, Brandão M, Calisto R, et al. Characteristics and Mortality of Patients With Cancer Diagnosed With SARS-CoV-2 in Northern Portugal. Anticancer Research. 2025. doi:10.21873/anticanres.17555
BibTeX
@article{TaveiraBarbosa2025,
author = {Taveira-Barbosa, José and Garcia, Teresa and Lebre, Ana and Fontes, Filipa and Brandão, Mariana and Calisto, Rita and Turé, Rubén and Bento, Maria José and Lunet, Nuno and Morais, Samantha and Lopes-Conceição, Luísa},
title = {Characteristics and Mortality of Patients With Cancer Diagnosed With SARS-CoV-2 in Northern Portugal},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17555}
}
EUVIMED